Selected Grants
An Open-Label, Randomized, Parallel Group Study to Assess the Safety and Efficacy of Hectorol® (doxercalciferol capsules) in Pediatric Patients with Chronic Kidney Disease Stages 3 and 4 with Secondary Hyperparathyroidism Not Yet on Dialysis
Clinical TrialPrincipal Investigator · Awarded by Sanofi US · 2018 - 2022External Relationships
- Akebia/Medpace
- American Board of Pediatrics, sub-board Pediatric Nephrology
- American Society of Pediatric Nephrology
- National Quality Forum
- Poiesis Medical
- Solutions for Patient Safety
- Up to Date
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.